Shigellosis is not a rare tropical disease confined to low-income settings. In the United States, the Centers for Disease Control and Prevention (CDC) estimates approximately 450,000 infections occur each year, leading to roughly 5,400 hospitalizations and 38 deaths. The causative agent, Shigella, is a genus of Gram-negative bacteria that produces an acute intestinal infection marked by fever, abdominal pain, and diarrhea that is frequently bloody. What distinguishes shigellosis from many other foodborne illnesses is not its frequency alone but the combination of an extraordinarily low infectious dose, multiple transmission routes, and a rapidly expanding problem of antimicrobial resistance that is narrowing the options available to clinicians.
Where Shigella Is Found and How It Spreads
Humans are the only natural reservoir for Shigella. The bacteria are shed in the feces of infected people, and transmission occurs through the fecal-oral route. Direct person-to-person spread is common in households, childcare settings, schools, and other congregate environments. Indirect transmission occurs through contaminated food, water, and fomites, and flies can serve as mechanical vectors. Sexual transmission, particularly among men who have sex with men, has become an increasingly prominent pathway in high-income countries.
The infectious dose is exceptionally low. Ingestion of as few as 10 to 100 organisms can cause disease, a characteristic that separates Shigella from many other enteric bacteria and helps explain its efficiency in institutional and food service settings. The bacteria are also relatively resistant to gastric acid, which allows a substantial proportion of an ingested dose to reach the intestine.
Foodborne transmission is well documented. A 2024 outbreak in Fairview Heights, Illinois, linked to a LongHorn Steakhouse resulted in 24 laboratory-confirmed Shigella infections and an additional 44 people reporting compatible illness, with nine hospitalizations. The St. Clair County Health Department and Illinois Department of Public Health investigated the event, and the restaurant voluntarily closed on October 2, 2024, to permit environmental assessment and corrective action. In 2020, Danish health authorities traced an outbreak to fresh mint purchased from local greengrocers and bazaars, noting that raw vegetables can become heavily contaminated and that the infectious dose is as low as 10 to 500 bacteria. Imported fresh herbs, including coriander, parsley, and basil, have been implicated in multiple Shigella sonnei outbreaks in Europe, and contaminated iceberg lettuce has been linked to an EU-wide event.
Waterborne and recreational water transmission also occurs. Shigellosis outbreaks have been associated with swimming pools, lakes, and untreated drinking water, particularly where sanitation is inadequate or where infected individuals enter shared water while symptomatic.
Signs and Symptoms
The incubation period for shigellosis is typically one to two days, though it can range from 12 hours to several days. The most common symptoms are diarrhea, which may contain blood or mucus; fever; abdominal pain or cramps; and tenesmus, the persistent sensation of needing to defecate even when the bowel is empty. Nausea and vomiting may also occur. In many patients, the illness is self-limited and resolves within five to seven days, but symptoms can persist longer in people who are immunocompromised or in poor health.
Severe presentations are not uncommon. The diarrhea can be profuse and bloody, and the combination of fever, abdominal pain, and bloody stools is the clinical picture of bacillary dysentery, the traditional name for the illness. Dehydration is a significant risk, particularly in young children and older adults, and can require hospitalization.
Who Is Most at Risk
Children under five years of age have the highest rate of infection in the United States. Their less developed immune systems and close contact in childcare and school settings facilitate transmission, and they are more likely to experience severe complications. Adults over 65 with underlying medical conditions are also at elevated risk for invasive disease and hospitalization.
Beyond these demographic groups, several populations bear a disproportionate burden. Men who have sex with men have experienced a marked increase in shigellosis diagnoses, and the European Centre for Disease Prevention and Control (ECDC) has identified this group as the focus of recent multidrug-resistant and extensively drug-resistant transmission clusters. People experiencing homelessness, those in correctional facilities, international travelers, and military personnel in deployed settings are also at increased risk due to crowding, limited access to hygiene infrastructure, or exposure to contaminated food and water. Immunocompromised individuals face a higher likelihood of severe illness and complications.
What Makes Shigella Dangerous
The danger of shigellosis operates on several levels.
First, the infection can produce severe, debilitating diarrhea that leads to dehydration, electrolyte imbalance, and, in vulnerable patients, hospitalization or death. The World Health Organization estimates that Shigella causes 80 to 165 million cases and approximately 600,000 deaths worldwide each year, with the majority of cases and deaths occurring in children.
Second, invasive complications can occur. Bacteremia, or bloodstream infection, is rare but is most likely in children under five and adults over 65 with underlying disease. Other complications include reactive arthritis, seizures in children, hemolytic uremic syndrome, and, rarely, intestinal perforation or myocarditis. These outcomes are uncommon in absolute terms but are serious when they occur.
Third, and increasingly significant, is antimicrobial resistance. Shigella has progressively acquired resistance to the antibiotics that have historically been used to treat severe infections. A 2026 CDC analysis of nearly 17,000 Shigella isolates collected between 2011 and 2023 found that the proportion classified as extensively drug-resistant rose from 0% in 2011–2015 to 8.5% in 2023. Extensively drug-resistant, or XDR, Shigella is defined as resistant to ampicillin, azithromycin, ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole—the five antibiotics most commonly used for first- and second-line treatment. No FDA-approved oral antimicrobial agents are available to treat these infections.
The epidemiological profile of XDR shigellosis differs from that of susceptible strains. Whereas earlier U.S. outbreaks primarily affected children, national surveillance data indicate that most XDR cases have occurred among adult men, and approximately one third of patients were hospitalized. The resistance genes carried by Shigella can also spread to other enteric bacteria, raising the possibility that resistance could become more widespread among foodborne pathogens. The ECDC has warned that more than 2,300 infections linked to seven genetically distinct MDR/XDR Shigella sonnei and Shigella flexneri clusters have been reported across Europe and the United States since 2023, with transmission concentrated among men who have sex with men.
Large-Scale Outbreaks in the Past Decade
The past decade has produced a series of outbreaks that illustrate the pathogen’s adaptability across transmission routes and geographic settings.
United Kingdom, 2021–2022. An outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei was identified in the UK beginning in September 2021. Seventy-two cases belonging to a single genomic cluster were described in a peer-reviewed analysis, with 97% of cases occurring in men and a median age of 34 years. The WHO reported that the UK was investigating a cluster of 84 XDR cases by March 2022, compared with only 16 cases in the preceding period. The outbreak was one of the first to demonstrate sustained transmission of an XDR strain in a high-income setting.
Cape Verde, 2025. Between October 1 and December 22, 2025, the UK Health Security Agency identified 109 reported cases of Shigella sonnei among British travelers returning from Cape Verde. Four British tourists died after contracting gastrointestinal illnesses linked to the bacterium. Professor Brendan Wren of the London School of Hygiene & Tropical Medicine noted that shigellosis outbreaks have been occurring in quality hotels on Cape Verde for at least three years, with more than 800 people affected. Dr. Damien Tully, also of LSHTM, identified buffet-style catering as a risk factor, noting that time, temperature, and touch are the key variables: food left too long in the 5–60°C “danger zone” allows bacteria to multiply rapidly, and poor hand hygiene among food handlers can contaminate shared serving utensils.
United States, 2024–2026. The LongHorn Steakhouse outbreak in Illinois in 2024 demonstrated that food service transmission remains a live threat. National surveillance data show that shigellosis cases have not declined. Provisional CDC figures recorded 13,921 cases through September 26, 2026, compared with 14,277 over the corresponding period in 2025. In the week ending October 3, 2026, 27 states and territories recorded more cases than at the same point in the previous year, with increases concentrated in the Northeast, Midwest, and West. California recorded the highest cumulative total, followed by New York City and Florida.
Institutional and community outbreaks. Shigellosis outbreaks in childcare centers, schools, and kindergartens are a recurring feature of the epidemiology. In November 2025, kindergartens in the village of Dylym in Dagestan were closed after a mass poisoning event in which Shigella was identified in ten victims; preliminary findings pointed to bacterial carriage among kindergarten staff who were unaware of their infection. In Bilbao, Spain, public health authorities investigated a school outbreak with at least four confirmed cases in October 2025, recalling a much larger school outbreak in Eibar in 2012 that affected more than a hundred people. A single confirmed case at an elementary school in Milwaukee, Wisconsin, in November 2024 prompted a comprehensive health response, reflecting the ease with which the organism spreads in settings with shared facilities and close contact.
Historical and travel-associated events. Outbreaks on cruise ships have been documented since at least the late 1980s, when a multiple-antibiotic-resistant strain of Shigella flexneri caused gastroenteritis aboard a Caribbean cruise. In 1994, more than 600 passengers on the Viking Serenade were infected with Shigella flexneri, and the ship was disinfected in port. More recent cruise-associated gastroenteritis outbreaks have involved multiple pathogens, but Shigella remains a recognized risk in closed environments with shared dining and sanitation facilities.
How People Can Protect Themselves
The primary defense against shigellosis is rigorous hygiene, particularly hand hygiene. Public health agencies consistently identify careful handwashing with soap and water as the single most important preventive measure. Hands should be washed after using the toilet, after changing diapers, before preparing or eating food, and after contact with animals or soil. Hand sanitizers can be useful, but they are less effective when hands are visibly dirty or greasy, and soap and water are preferred.
Food safety practices matter. People with diarrhea should not prepare food or drinks for others. Kitchen utensils, plates, cutting boards, and counter surfaces should be cleaned and sanitized during and after food preparation. Ready-to-eat foods should be handled with gloves, tongs, or utensils rather than bare hands. Fruits and vegetables eaten raw should be washed thoroughly, although rinsing alone may not reliably eliminate Shigella from produce with uneven surfaces.
Travelers should follow safe food and water practices, including drinking bottled or boiled water where the local supply is not reliably safe, avoiding ice made from untreated water, and washing hands frequently. The Cape Verde outbreaks illustrate that even quality hotel settings can be venues for transmission, particularly where buffet-style service and shared utensils are involved.
Sexual health measures are relevant for populations at risk of sexually transmitted shigellosis. The ECDC advises avoiding sexual activity during diarrheal illness and seeking medical care for severe or persistent symptoms. Healthcare providers are encouraged to consider Shigella in patients with gastroenteritis who report relevant sexual histories and to perform antimicrobial susceptibility testing when treatment is required.
For clinical management, oral rehydration is the cornerstone of supportive care for mild illness. Antimotility agents should be avoided because they can prolong fever, diarrhea, and bacterial shedding. Antibiotics are recommended for severe illness and for patients with risk factors for severe disease, but the choice of agent is complicated by resistance, and susceptibility testing is increasingly important to guide therapy.
Conclusion
Shigellosis is a preventable illness, but the record of the past decade shows that prevention is not being achieved consistently. The pathogen’s low infectious dose, multiple transmission routes, and capacity to acquire resistance to the antibiotics used to treat severe cases make it a persistent public health challenge. Outbreaks in restaurants, hotels, schools, and sexual networks demonstrate that the risk is not confined to any single setting or population. The rise of extensively drug-resistant strains, now accounting for a measurable and growing proportion of U.S. isolates, adds urgency to surveillance, susceptibility testing, and infection control. For individuals, the measures are straightforward: hand hygiene, safe food and water practices, and prompt medical attention for severe or prolonged diarrheal illness. For public health systems, the task is to ensure that those measures are supported by adequate infrastructure, timely outbreak detection, and a treatment landscape that has not been eroded by resistance.
